To date, it is known that about 10% of the disease-causing variants consist of LDLR CNVs, so the opportunity for the simultaneous detection of the entire spectrum of the LDLR variants is crucial for achieving a definitive molecular diagnosis of FH. The gene discussed is LDLR; the disease is familial hyperaldosteronism.